BSRC Alexander Fleming

BSRC "Alexander Fleming" Publications - 2017

2017 - (13)

Tzouvelekis A, Bouros D, Aidinis V. 2017, "Biomarkers in Idiopathic Pulmonary Fibrosis: A RAGE-ing Bull in the Arena", Ann Am Thorac Soc., 2017 May; 14(5):613-614 [PubMed].

Melagraki G, Ntougkos E, Rinotas V, Papaneophytou C, Leonis G, Mavromoustakos T, Kontopidis G, Douni E, Afantitis A, Kollias G. 2017, "Cheminformatics-aided discovery of small-molecule Protein-Protein Interaction (PPI) dual inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)", PLoS Comput Biol., 2017 Apr 20; 13(4):e1005372. doi: 10.1371/journal.pcbi.1005372 [PubMed].

Ntougkos E, Chouvardas P, Roumelioti F, Ospelt C, Frank-Bertoncelj M, Filer A, Buckley CD, Gay S, Nikolaou C, Kollias G. 2017, "Genomic responses of mouse synovial fibroblasts during TNF-driven arthritogenesis greatly mimic those of human rheumatoid arthritis", Arthritis Rheumatol, 2017 Apr 13. doi: 10.1002/art.40128 [PubMed].

Terzenidou ME, Segklia A, Kano T, Papastefanaki F, Karakostas A, Charalambous M, Ioakeimidis F, Papadaki M, Kloukina I, Chrysanthou-Piterou M, Samiotaki M, Panayotou G, Matsas R, Douni E. 2017, "Novel insights into SLC25A46-related pathologies in a genetic mouse model", PLoS Genet, Apr 4;13(4): e1006656. doi: 10.1371 [PubMed].

Karampitsakos T, Tzilas V, Tringidou R, Steiropoulos P, Aidinis V, Papiris SA, Bouros D, Tzouvelekis A. 2017, "Lung cancer in patients with idiopathic pulmonary fibrosis", Pulm Pharmacol Ther., 2017 Apr 1 [PubMed].

Koliaraki V, Pallangyo CK, Greten FR, Kollias G. 2017, "Mesenchymal Cells in Colon Cancer", Gastroenterology, 2017 Apr;152(5): 964-979. doi: 10.1053/j.gastro.2016.11.049. Review [PubMed].

Frank-Bertoncelj M, Trenkmann M, Klein K, Karouzakis E, Rehrauer H, Bratus A, Kolling C, Armaka M, Filer A, Michel BA, Gay RE, Buckley CD, Kollias G, Gay S, Ospelt C. 2017, "Epigenetically-driven anatomical diversity of synovial fibroblasts guides joint-specific fibroblast functions", Nat Commun., 2017 Mar 23; 8:14852. doi: 10.1038/ncomms14852 [PubMed].

Tomos IP, Tzouvelekis A, Aidinis V, Manali ED, Bouros E, Bouros D, Papiris SA. 2017, "Extracellular matrix remodeling in idiopathic pulmonary fibrosis. It is the 'bed' that counts and not 'the sleepers’", Expert Rev Respir Med, 2017 Mar 8 :1-11. [PubMed].

Tzouvelekis A, Yu G, Lacks Lino Cardenas C, Herazo-Maya JD, Wang R, Woolard T, Zhang Y, Sakamoto K, Lee H, Yi JS, DeIuliis G, Xylourgidis N, Ahangari F, Lee PJ, Aidinis V, Herzog EL, Homer R, Bennett AM, Kaminski N. 2017, "SH2 Domain-containing Phosphatase-SHP-2 is a Novel Anti-fibrotic Regulator in Pulmonary Fibrosis", Am J Respir Crit Care Med., 2017 Feb 15; 195(4):500-514. [PubMed].

Anas AA, Claushuis TA, Mohan RA, Christoffels VM, Aidinis V, Florquin S, Van't Veer C, Hou B, de Vos AF, van der Poll T. 2017, "Epithelial Myeloid-differentiation Factor 88 is Dispensable During Klebsiella Pneumonia", Am J Respir Cell Mol Biol., 2017 Feb 10. [PubMed].

Tzouvelekis A, Tzilas V, Papiris S, Aidinis V, Bouros D. 2017, "Diagnostic and prognostic challenges in Idiopathic Pulmonary Fibrosis A patient "Q and A" approach", Pulm Pharmacol Ther., 2017 Feb; 42:21-24. [PubMed].

Fouka P., Alexopoulos H., Chatzi I., Dedos S. G., Samiotaki M., Panayotou G., Politis P., Tzioufas A., Dalakas M. C. 2017, "Antibodies to inositol 1,4,5-triphosphate receptor 1 in patients with cerebellar disease.", Neurology: Neuroimmunology & Neuroinflammation, 2016 Dec 5; 4(1):e306. eCollection 2017 Jan [PubMed].

Mylonis I., Kourti M., Samiotaki M., Panayotou G., Simos G. 2017, "Mortalin-mediated and ERK-controlled targeting of HIF-1α to mitochondria confers resistance to apoptosis under hypoxia", J Cell Sci. , 2017 Jan 15; 130(2):466-479. doi: 10.1242/jcs.195339. Epub 2016 Dec 1. [PubMed].